Wikipedia

Giorgio Walter Canonica

Giorgio Walter Canonica (Born October 25, 1947) is an Italian allergist, pulmonologist and professor of Respiratory Medicine at Humanitas University, Milan, Italy and Director Personalized Medicine Asthma & Allergy Center at Humanitas Research Hospital IRCCS-Milano Italy since December 2016.[1] He is known for his research work related to innovative treatment strategies for allergic diseases which includes biological response modifier in form of targeted immunotherapy with primary emphasis on sublingual immunotherapy (SLIT).[2] He served as President of several International or national Allergy and Respiratory Scientific Societies.[3]

Giorgio Walter Canonica
Giorgio Walter Canonica
Born(1947-10-25)October 25, 1947
CitizenshipItalian
Alma mater University of Genoa, Milan, Italy
Scientific career
InstitutionsMedical University of South Carolina
Uppsala University
Humanitas University, Milan
World Allergy Organization
Global Asthma Association (INTERASMA)

Early life and education

edit

Canonica received his master's degree from School of Medicine, University of Genoa during 1972. He started his career as a specialist in pulmonary disease at University of Genoa. He then moved to Florence University while keeping the primary specialization in Allergy and Clinical Immunology. Consequently, he carried out research works in clinical immunology and allergology research from University of Uppsala, Sweden and Medical University of South Carolina, Charleston, USA.[3]

Career

edit

Canonica returned to Genoa University in 1995 and served at different positions including the full professor Internal Medicine and Pulmonary Medicine, Director of the Speciality School of Allergy and Clinical Immunology, Director of the Specialty School of Pulmonary Diseases, Chairman of the Department of Medical Specialties (University Hospital San Martino Genoa, Italy). In 2016 he moved to Humanitas University and Research Hospital in Milan.[4] As per national and international awards and recognition obtained, in 2004 Canonica received the title of Visitante Distinguido from Università Catolica Cordoba Argentina.[5] Later on, in 2012, he won the WAO Gold Medal Award.[6] In 2014, he received the Laurea Honoris Causa, Cluji Medical University, Romania.[7] He also received the Special Recognition Award from WAO in 2019.[8][9][10] He is also currently serving as Editor in chief of Current Opinion in Allergy and Clinical Immunology.[11]

In 2020, he obtained the Scientific Recognition Award APAAACI-Asian Pacific Association Allergy.[12] He was declared Legend of Allergy and Immunology in 2021.[13] In 2022, he obtained the Lifetime Achievement Award – APAACI-Asian Pacific Association Allergy Clinical Immunology in Manila.[14] Another Lifetime Achievement Award was obtained in 2023 from the WAO World Allergy Organization, in Dubai.[15]

Throughout his career, Professor Canonica has served as President of several international and national associations. He chaired the World Allergy Organization (WAO) from 2007 to 2009[16]; he served as President for Interasma-Global Asthma Association from 2018 to 2020.[17][18] In the very last years, he’s been President of the Respiratory Effectiveness Group (REG) from 2022 to 2024,[19] continuing his research activities on the effectiveness of respiratory treatments.[20]

At the national level, Professor G.W. Canonica has held positions as President of the Italian Society of Allergology, Asthma, and Clinical Immunology (SIAAIC),[21] and the Italian Society of Respiratory Medicine (SIMER),[22] known as SIP/IRS. He was also involved in the Collegium Internationale Allergologicum (CIA) as a Board member from 2021 to 2023.[23] This position made him contribute to international collaboration and knowledge exchange in the field of allergology. Currently, Professor Canonica is an executive member and consultant in many important international initiatives and networks: Member of the executive committee of the Allergic Rhinitis and its Impact on Asthma (ARIA),[24] and the Global Allergy & Asthma Excellence Network (GA²LEN),[25] Canonica is also serving as Chief Executive Director of Interasma since 2021.[26][27]

Professor Canonica has made significant contributions as Chair of the Methodology Committee at the EAACI since 2019,[28] and as Chair of Biologics in Allergy at WAO from 2023 to 2024, leading important initiatives in research and therapeutic innovation.[29] His involvement as an International Advocate at the Global Asthma Initiative (GINA)[30] has contributed to the promotion of best clinical practices and awareness about asthma management globally.

Furthermore, Professor Canonica is honored as a Honorary Member of several societies, including the Argentine Society of Allergology,[31] the Latin American Society of Allergy and Immunology (SLAAI),[32] the Finnish Society of Allergy and Immunology,[33] the Hungarian Allergy Society,[34] the Romanian Allergy Society,[35] and the Italian Association of Nasal Cytology (AICNA).[36]

He is also recognized as a Fellow of esteemed organizations such as the American Academy of Allergy Asthma and Immunology (AAAAI),[37] the European Respiratory Society (ERS),[38] the European Academy of Allergy and Clinical Immunology (EAACI),[39] the American College of Allergy Asthma and Immunology (ACAAI),[40] and the American College of Chest Physicians (ACCP).[41]

Research areas

edit

Canonica's research areas primarily include the observations of molecular events, which further includes interactivity of epithelial cells, inflammatory cells and immunocompetent cells in allergic inflammation and airway remodeling. He is also known to be involved in innovative treatment strategies for allergic diseases including biological response modifier in form of targeted immunotherapy with primary emphasis on sublingual immunotherapy (SLIT).[7]

Notable publications

edit
  • Zuberbier, T.; Aberer, W.; Asero, R.; Abdul Latiff, A. H.; Baker, D.; Ballmer-Weber, B.; Bernstein, J. A.; Bindslev-Jensen, C.; Brzoza, Z.; Buense Bedrikow, R.; Canonica, G. W.; Church, M. K.; Craig, T.; Danilycheva, I. V.; Dressler, C.; Ensina, L. F.; Giménez-Arnau, A.; Godse, K.; Gonçalo, M.; Grattan, C.; Hebert, J.; Hide, M.; Kaplan, A.; Kapp, A.; Katelaris, C. H.; Kocatürk, E.; Kulthanan, K.; Larenas-Linnemann, D.; Leslie, T. A.; Magerl, M.; Mathelier-Fusade, P.; Meshkova, R. Y.; Metz, M.; Nast, A.; Nettis, E.; Oude-Elberink, H.; Rosumeck, S.; Saini, S. S.; Sánchez-Borges, M.; Schmid-Grendelmeier, P.; Staubach, P.; Sussman, G.; Toubi, E.; Vena, G. A.; Vestergaard, C.; Wedi, B.; Werner, R. N.; Zhao, Z.; Maurer, M. (July 2018). "The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria". Allergy. 73 (7): 1393–1414. doi:10.1111/all.13397. hdl:10230/35554. PMID 29336054.
  • Brożek, Jan L.; Bousquet, Jean; Baena-Cagnani, Carlos E.; Bonini, Sergio; Canonica, G. Walter; Casale, Thomas B.; van Wijk, Roy Gerth; Ohta, Ken; Zuberbier, Torsten; Schünemann, Holger J. (September 2010). "Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision" (PDF). Journal of Allergy and Clinical Immunology. 126 (3): 466–476. doi:10.1016/j.jaci.2010.06.047. hdl:1822/49100. PMID 20816182. S2CID 536060.
  • Canonica, G. W.; Baena-Cagnani, C. E.; Bousquet, J.; Bousquet, P. J.; Lockey, R. F.; Malling, H.-J.; Passalacqua, G.; Potter, P.; Valovirta, E. (8 February 2007). "Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce: Recommendations for immunotherapy clinical trials". Allergy. 62 (3): 317–324. doi:10.1111/j.1398-9995.2006.01312.x. PMID 17298350. S2CID 16237704.

References

edit
  1. ^ Varricchi, Gilda; Senna, Gianenrico; Loffredo, Stefania; Bagnasco, Diego; Ferrando, Matteo; Canonica, Giorgio Walter (2017). "Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?". Frontiers in Immunology. 8: 242. doi:10.3389/fimmu.2017.00242. ISSN 1664-3224. PMC 5344894. PMID 28344579.
  2. ^ "Giorgio Walter Canonica". Hunimed. Retrieved 2020-10-13.
  3. ^ a b "Academy of Europe: Canonica Giorgio Walter". www.ae-info.org. Retrieved 2020-10-13.
  4. ^ Academy of Europe: CV". www.ae-info.org. Retrieved 2025-01-07
  5. ^ "Universidad Católica de Córdoba". www.ucc.edu.ar. Retrieved 2025-01-07
  6. ^ "Academy of Europe: Canonica Giorgio Walter". https://www.ae-info.org/ae/Member/Canonica_Giorgio_Walter. Retrieved 2025-01-07
  7. ^ a b "SRxA | Professor Giorgio Walter Canonica". www.srxa.com. Retrieved 2020-10-13.
  8. ^ "Resume - Giorgio Walter Canonica" (PDF).
  9. ^ "Academy of Europe: CV". www.ae-info.org. Retrieved 2020-10-13.
  10. ^ "Giorgio Walter Canonica - Professor of Pediatrics Allergy and Immunology, Respiratory Therapy in Genova, Liguria, Italy | eMedEvents". www.emedevents.com. Retrieved 2020-10-13.
  11. ^ "Editorial introductions". Current Opinion in Allergy and Clinical Immunology. 9 (1): vii–x. 2009. doi:10.1097/ACI.0b013e328324b654. ISSN 1528-4050.
  12. ^ https://www.apaaaci.org/
  13. ^ https://pubmed.ncbi.nlm.nih.gov/34610159/
  14. ^ https://www.apaaaci.org/
  15. ^ https://www.worldallergy.org/wao
  16. ^ https://openi.nlm.nih.gov/detailedresult?img=PMC3488903_waoj-4-231-g014&req=4
  17. ^ "Professor Giorgio Walter Canonica". www.aminer.cn. Retrieved 2021-07-05.
  18. ^ "Expertise in Asthma: Giorgio Walter Canonica - Interasma's Chief Executive Director". GAA Interasma. Retrieved 2021-07-05.
  19. ^ https://www.regresearchnetwork.org/the-reg-team/
  20. ^ https://www.erasmus.gr/microsites/1280
  21. ^ Rossi, Oliviero; Massaro, Ilaria; Caminati, Marco; Quecchia, Cristina; Fassio, Filippo; Heffler, Enrico; Canonica, Giorgio Walter (2015-08-04). "Escaping the trap of allergic rhinitis". Clinical and Molecular Allergy. 13 (1): 17. doi:10.1186/s12948-015-0023-y. ISSN 1476-7961. PMC 4524393. PMID 26244040.
  22. ^ "Editorial introductions". Current Opinion in Allergy and Clinical Immunology. 4 (1): i. February 2004. ISSN 1528-4050.
  23. ^ Kaliner, Michael A. (2011-01-01). "History of the World Allergy Organization: Two Decades Leading to World Leadership, 1990-2010". World Allergy Organization Journal. 4 (11): 231–248. doi:10.1097/WOX.0b013e31823ba552. ISSN 1939-4551. PMC 3488903. PMID 23268440.
  24. ^ "Professor G. Walter Canonica, MD | The AIT Network". www.theaitnetwork.com. Retrieved 2021-07-05.
  25. ^ "Academy of Europe - Giorgio Walter Canonica". www.ae-info.org. Retrieved 2021-07-05.
  26. ^ "Professor Giorgio Walter Canonica". www.aminer.cn. Retrieved 2021-07-05.
  27. ^ "Expertise in Asthma: Giorgio Walter Canonica - Interasma's Chief Executive Director". GAA Interasma. Retrieved 2021-07-05.
  28. ^ Kostaras, Charalampos. "Science Committee | EAACI.org". www.eaaci.org. Retrieved 2021-07-05.
  29. ^ https://www.worldallergy.org/wao
  30. ^ Canonica, Giorgio Walter (2020-11-25). "COVID-19 Pandemic Allergen specific Immunotherapy Positioning in Respiratory Allergy". US Respiratory & Pulmonary Diseases. 5: 10. doi:10.17925/USPRD.2020.5.1.10. S2CID 234941178.
  31. ^ https://www.ae-info.org/ae/Member/Canonica_Giorgio_Walter
  32. ^ https://www.ae-info.org/ae/Member/Canonica_Giorgio_Walter
  33. ^ https://www.ae-info.org/ae/Member/Canonica_Giorgio_Walter
  34. ^ https://www.ae-info.org/ae/Member/Canonica_Giorgio_Walter
  35. ^ https://www.ae-info.org/ae/Member/Canonica_Giorgio_Walter
  36. ^ https://www.ae-info.org/ae/Member/Canonica_Giorgio_Walter
  37. ^ https://www.ae-info.org/ae/Member/Canonica_Giorgio_Walter
  38. ^ https://www.ae-info.org/ae/Member/Canonica_Giorgio_Walter
  39. ^ https://www.ae-info.org/ae/Member/Canonica_Giorgio_Walter
  40. ^ https://www.ae-info.org/ae/Member/Canonica_Giorgio_Walter
  41. ^ https://www.ae-info.org/ae/Member/Canonica_Giorgio_Walter

See also

edit
Retrieved from "https://en.wiki.x.io/w/index.php?title=Giorgio_Walter_Canonica&oldid=1277158007"